NeuroLF: The best small and mobile dedicated brain PET scanner for an accessible early detection of Alzheimer’s disease

Project description

Easier brain scans for AD diagnosis

Among older people in Europe, dementia is the leading cause of dependency and disability. Alzheimer's disease (AD) is the most common type of dementia and early diagnosis is key to its treatment. Currently, a positron emission tomography scan, commonly known as a PET scan, is used to reveal the early microscopic changes in the brain caused by Alzheimer’s disease. However, PET scans are big and expensive, making population-wide screening difficult. The Swiss start-up Positrigo is developing the NeuroLF brain PET system, which is only a tenth of the price (reduced device, personnel and radiotracers costs) and a fifth of the size of traditional scanners. The EU-funded NeuroLF project will focus on the commercialisation of this new technology, which will make brain scanning affordable for everyone.

Fields of science

• agricultural sciences › animal and dairy science › pets
• natural sciences › physical sciences › theoretical physics › particle physics
• medical and health sciences › basic medicine › neurology › alzheimer
• social sciences › economics and business › business and management › commerce

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

POSITRIGO AG

Address

Technoparkstrasse 1
8005 Zurich
Switzerland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 2 246 666,80